Development of a novel regenerative therapy for malignant bone tumors using an autograft containing tumor inactivated

Yuanjiaozi Li1, Yasuhiro Katayama1, Ie Nie1

  • 1Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Regenerative Therapy
|March 16, 2023
PubMed

Insights

High hydrostatic pressurization (HHP) therapy effectively inactivates osteosarcoma (OS) cells and tumors. This novel approach preserves bone tissue, creating tumor-free autologous grafts for defect reconstruction and avoiding amputation.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Regenerative Medicine

Background:

  • Surgical resection of malignant bone tumors creates defects requiring reconstruction to prevent amputation.
  • Autologous bone grafts are ideal for reconstruction but pose challenges when contaminated with tumors.
  • Novel methods are needed to eliminate tumor cells while preserving graft viability.

Purpose of the Study:

  • To evaluate high hydrostatic pressurization (HHP) therapy for inactivating osteosarcoma (OS) cells and bone.
  • To determine if HHP can create tumor-free autologous bone grafts for defect reconstruction.
  • To assess the preservation of native bone extracellular matrix (ECM) after HHP treatment.

Main Methods:

  • Osteosarcoma (OS) cell line (LM8) and tumor tissues were subjected to HHP at 200 MPa for 10 minutes.
  • Cell inactivation was confirmed using morphological observation, WST-8 assay, and live/dead assay.
  • Inactivated OS cells and tissues were implanted into murine tibias to assess tumor growth and graft viability.

Main Results:

  • HHP treatment at 200 MPa for 10 minutes completely inactivated OS cells.
  • Inactivated OS cells and tumors did not proliferate after implantation.
  • HHP-treated bone was successfully prepared as tumor-free autologous bone tissue, demonstrating complete OS eradication.

Conclusions:

  • High hydrostatic pressurization (HHP) is a viable method for eradicating osteosarcoma in bone.
  • HHP preserves the native bone extracellular matrix (ECM), enabling the creation of transplantable, tumor-free autologous bone grafts.
  • This technique offers a promising solution for reconstructing bone defects caused by malignant bone tumors, potentially avoiding amputation.